Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015 (2015), Article ID 689531, 7 pages
http://dx.doi.org/10.1155/2015/689531
Research Article

Brand Name and Generic Proton Pump Inhibitor Prescriptions in the United States: Insights from the National Ambulatory Medical Care Survey (2006–2010)

1Division of Gastroenterology & Hepatology, University of Utah, Salt Lake City, UT 84132, USA
2Center for Healthcare Studies, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
3Division of General Internal Medicine and Geriatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
4Division of Gastroenterology & Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
5Department of Otolaryngology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA

Received 23 October 2014; Accepted 29 December 2014

Academic Editor: Eldon A. Shaffer

Copyright © 2015 Andrew J. Gawron et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. J. Shaheen, R. A. Hansen, D. R. Morgan et al., “The burden of gastrointestinal and liver diseases, 2006,” The American Journal of Gastroenterology, vol. 101, no. 9, pp. 2128–2138, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. American Gastroenterological Association, Choosing Wisely: Five Things Physicians and Patients Should Question, 2012, http://www.choosingwisely.org/.
  3. P. O. Katz, L. B. Gerson, and M. F. Vela, “Guidelines for the diagnosis and management of gastroesophageal reflux disease,” The American Journal of Gastroenterology, vol. 108, no. 3, pp. 308–328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. S. R. Schwartz, S. M. Cohen, S. H. Dailey et al., “Clinical practice guideline: hoarseness (Dysphonia),” Otolaryngology: Head and Neck Surgery, vol. 141, no. 3, pp. S1–S31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. S. Haas, K. A. Phillips, E. P. Gerstenberger, and A. C. Seger, “Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997–2000,” Annals of internal medicine, vol. 142, no. 11, pp. 891–897, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. AHRQ Executive Summary: Effective Health Care Program Management Strategies for Gastroesophageal Reflux Disease: An Update.
  7. Office of Generic Drugs US Food and Drug Administration, Facts about Generic Drugs, 2012.
  8. A. J. Gawron, D. D. French, J. E. Pandolfino, and C. W. Howden, “Economic evaluations of gastroesophageal reflux disease medical management,” PharmacoEconomics, vol. 32, no. 8, pp. 745–758, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. National Center for Health Statistics, NAMCS Micro-Data File Documentation, 2006.
  10. J. Zhang and K. F. Yu, “What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes,” Journal of the American Medical Association, vol. 280, no. 19, pp. 1690–1691, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Zou, “A modified poisson regression approach to prospective studies with binary data,” American Journal of Epidemiology, vol. 159, no. 7, pp. 702–706, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. National Center for Health Statistics, NAMCS Micro-Data File Documentation, 2006.
  13. Teva Pharmaceuticals Industries L, Teva Reaches Settlement Agreement with Pfizer and Nycomed Regarding Generic Protonix (Pantoprazole) Tablets, 2013.
  14. Medi-Span, September 2013, http://www.medispan.com.
  15. “Omeprazole delayed release tablet 20 mg,” 2014, http://www.walmart.com/ip/Equate-Delayed-Release-Tables-20Mg-Acid-Reducer-Omeprazole-28ct/10324783?action=product_interest&action_type=title&placement_id=irs_top&strategy=PWVAV&visitor_id=55542270420&category=0:976760:976798:1001540&client_guid=137b9e33-8445-40bd-b040-72d2cca4167b&config_id=2&parent_item_id=10324782&guid=3b3880de-cbad-4116-a927-b90867c09735&bucket_id=irsbucketdefault&findingMethod=p13n.
  16. “Omeprazole acid reducer tablets,” http://www.walgreens.com/store/c/walgreens-omeprazole-acid-reducer-tablets/ID=prod3895075-product.
  17. E. Remák, R. E. Brown, C. Yuen, and A. Robinson, “Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK,” Current Medical Research and Opinion, vol. 21, no. 10, pp. 1506–1517, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. O. K. Duru, S. L. Ettner, N. Turk et al., “Potential savings associated with drug substitution in medicare part into action for diabetes (TRIAD) Study,” Journal of General Internal Medicine, vol. 29, no. 1, pp. 230–236, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Aitken, E. R. Berndt, and D. M. Cutler, “Prescription drug spending trends in the united states: looking beyond the turning point,” Health Affairs, vol. 28, no. 1, pp. w151–w160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. A. Fischer and J. Avorn, “Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans,” Health Services Research, vol. 38, no. 4, pp. 1051–1063, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Granlund, “Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?” Social Science and Medicine, vol. 69, no. 11, pp. 1643–1650, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Okike, R. V. O'Toole, A. N. Pollak et al., “Survey finds few orthopedic surgeons know the costs of the devices they implant,” Health Affairs, vol. 33, no. 1, pp. 103–109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. A. J. Epstein, S. H. Busch, A. B. Busch, D. A. Asch, and C. L. Barry, “Does exposure to conflict of interest policies in psychiatry residency affect antidepressant prescribing?” Medical Care, vol. 51, no. 2, pp. 199–203, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. M. King, C. Essick, P. Bearman, and J. S. Ross, “Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis,” British Medical Journal, vol. 346, no. 7896, article f264, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. K. E. Austad, J. Avorn, J. M. Franklin, E. G. Campbell, and A. S. Kesselheim, “Association of marketing interactions with medical trainees' knowledge about evidence-based prescribing: results from a national survey,” JAMA Internal Medicine, vol. 174, no. 8, pp. 1283–1290, 2014. View at Publisher · View at Google Scholar
  26. National Institute for Health Care Management Research and Educational Foundation, A Primer: Generic Drugs, Patents and the Pharmaceutical Marketplace, 2002.
  27. T. A. Brennan and T. H. Lee, “Allergic to generics,” Annals of Internal Medicine, vol. 141, no. 2, pp. 126–130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. A. R. Robinson, K. B. Hohmann, J. I. Rijkin et al., “Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship,” Archives of Internal Medicine, vol. 164, no. 4, pp. 427–432, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. W. H. Shrank, E. R. Cox, M. A. Fischer, J. Mehta, and N. K. Choudhry, “Patients' perceptions of generic medications,” Health Affairs, vol. 28, no. 2, pp. 546–556, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. M. D. Drepper, L. Spahr, and J. L. Frossard, “Clopidogrel and proton pump inhibitors—where do we stand in 2012?” World Journal of Gastroenterology : WJG, vol. 18, no. 18, pp. 2161–2171, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. N. S. Abraham, M. A. Hlatky, E. M. Antman et al., “ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID Use,” The American Journal of Gastroenterology, vol. 105, no. 12, pp. 2533–2549, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. R. M. Roberts and L. A. Hicks, “Appropriate antibiotic use: family physicians have the power of the pen,” American Family Physician, vol. 86, no. 9, article 810, 2012. View at Google Scholar · View at Scopus